TM7SF2 has been identified as a critical regulator of cholesterol biosynthesis and steroid metabolism in lung cancer cells, a finding central to overcoming chemoresistance in NSCLC [28]. Here, TM7SF2 is linked to non-small cell lung carcinoma.